Home » Topics » Disease categories and therapies » Inflammatory

Inflammatory
RSS

NIH grants support work at Feinstein Institute on bioelectronic medicine and sepsis

Aug. 19, 2016

Hutchison MediPharma patents PI3K inhibitors

Aug. 18, 2016

SAMD9 mutations cause new form of syndromic adrenal hypoplasia

July 29, 2016

InflaRx raises funds in series C financing

July 25, 2016

Mutations in TRMT10C identified as a cause of mitochondrial disease

July 15, 2016

Animal model studies give insight into mechanisms of disease

June 6, 2016

Bayer Schering Pharma patents factor XIa and KLKB1 inhibitors

April 7, 2016

p53 might be useful to distinguish Langerhans cell hyperplasia from Langerhans cell histiocytosis

March 10, 2016

Acetazolamide counters effects of Klotho hypomorphism on aging

Jan. 20, 2016

Eagle Pharmaceuticals reports phase II results for dantrolene in exertional heat stroke

Dec. 22, 2015

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 8, 2026.
First measles treatment advances as vaccination rates drop
BioWorld
Scientists at the La Jolla Institute for Immunology have identified and characterized human antibodies that neutralize the measles virus by blocking its entry...
Infensa Bioscience identifies new ASIC blockers
BioWorld Science
Infensa Bioscience Pty Ltd. has patented new acid-sensing ion channel 1 (ASIC) blockers potentially useful for the treatment of stroke, among others.
Hantavirus is ‘sentinel’ more than acute pandemic threat
BioWorld
News of eight infections and three deaths so far due to an emerging zoonotic virus has brought back unhappy memories of the early days of SARS-CoV-2. At a press...
Italy’s Angelini pays $4.1B cash for rare disease specialist Catalyst
BioWorld
Italian family-owned Angelini Pharma SpA is making its first move into the U.S. market, acquiring rare diseases specialist Catalyst Pharma Inc. in an all-cash...